Evidence mapPaperPMID 42218151Full record

ArticleNature communications2026

Two Plasmodium vivax hypnozoite-expressed RNA-binding proteins inhibit liver stage replication.

Kim Chi Vo, Riëtte van Biljon, Gigliola Zanghi, Bryan Zavala, William Betz, Charlie Jennison, Ashley M Vaughan, Heather J Painter, Stefan H I Kappe

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Update of
    Two2025
5 · Who and what money

Authors and funding

9 authors.

Kim Chi Vo *Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA. kvo@som.umaryland.edu.ORCID http://orcid.org/0000-0001-5042-0466
Riëtte van Biljon *Division of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.ORCID http://orcid.org/0000-0002-1710-0441
Gigliola ZanghiCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-9656-9642
Bryan ZavalaDivision of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
William BetzCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Charlie JennisonCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-8138-9999
Ashley M VaughanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-5815-756X
Heather J PainterDivision of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.ORCID http://orcid.org/0000-0003-0264-4689
Stefan H I KappeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA. SKappe@som.umaryland.edu.ORCID http://orcid.org/0000-0003-1540-1731

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmodium vivax (Pv) forms non-replicating liver stages called hypnozoites, which activate after primary infection, and cause relapses of symptomatic blood-stage malaria. We hypothesize that hypnozoites must actively suppress schizogony to maintain a quiescent state. Differential transcriptome prospecting identifies two hypnozoite-expressed transcripts encoding putative RNA-binding proteins. We assess the functional role of the two encoded proteins in Plasmodium yoelii (Py), a rodent malaria parasite that naturally does not form hypnozoites. Strikingly, individual expression of each protein in Py liver stages blocks liver stage schizogony, with parasites remaining small and uninucleate. A screen of RNA sequences that interact with the putative RNA-binding domains of these proteins shows enrichment of distinct, highly specific motifs, indicating that they might block schizogony by binding RNAs containing these motifs. Our findings provide the unprecedented functional evidence for one potential molecular mechanism of hypnozoite formation. Based on their function we name these proteins IESI-1 and IESI-2 (Initiation of Exo-erythrocytic Schizogony Inhibited).

Indexed as

LiverPlasmodium vivaxProtozoan ProteinsRNA-Binding ProteinsAnimalsMicePlasmodium yoeliiProtozoan ProteinsRNA-Binding Proteins

Identifiers

PMID42218151
PMCPMC13392028

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.